Aloe Vera and Fatty Liver: Evidence and Safety

Aloe vera good for fatty liver is a question increasingly asked by people managing metabolic liver conditions, particularly as interest in natural remedies grows. Fatty liver disease, now more commonly called metabolic dysfunction-associated steatotic liver disease (MASLD), affects a significant proportion of UK adults and is primarily managed through lifestyle changes. While aloe vera has a long history in traditional medicine, understanding what the current evidence actually shows, and where the safety risks lie, is essential before considering it alongside any NHS-recommended treatment plan.

What is fatty liver disease and how is it managed on the NHS?

Fatty liver disease, now termed MASLD, is managed on the NHS primarily through lifestyle modification, as no MHRA-licensed drug treatment for MASLD currently exists. NICE guidance (NG49) recommends addressing weight, diet and physical inactivity as first-line interventions.

Fatty liver disease is a condition in which excess fat accumulates within liver cells, and it is broadly divided into two main types: metabolic dysfunction-associated steatotic liver disease (MASLD, previously called non-alcoholic fatty liver disease or NAFLD) and alcohol-related liver disease (ALD). MASLD is now the most common chronic liver condition in the UK, closely linked to obesity, type 2 diabetes, high cholesterol and insulin resistance.^[1][2] When inflammation develops alongside liver fat, this is referred to as metabolic dysfunction-associated steatohepatitis (MASH), which carries a higher risk of progression to fibrosis and cirrhosis. In many people MASLD causes no symptoms in its early stages, and importantly it can be present even when liver enzyme results appear normal. Without management it can progress to inflammation, fibrosis, cirrhosis and, in some cases, liver failure.

The NHS manages fatty liver disease primarily through lifestyle modification rather than medication, as there is currently no licensed drug treatment specifically approved by the MHRA for MASLD (correct at the time of writing; readers should check MHRA and NICE updates for any changes).^[5][6] NICE guidance (NG49) recommends that clinicians identify and address underlying risk factors, including excess body weight, physical inactivity and poor diet.

Diagnosis and risk stratification typically begin in primary care. NICE NG49 recommends using the FIB-4 score as a first-line non-invasive test to assess fibrosis risk, with enhanced liver fibrosis (ELF) testing used to confirm intermediate or high-risk results.^[3][4] Ultrasound can detect steatosis but does not reliably assess the degree of fibrosis. A FibroScan or liver biopsy may be used where further assessment is needed. People with significant fibrosis or other high-risk features are typically referred to hepatology. Regular monitoring is recommended for those with more advanced disease, with the interval and pathway determined by individual risk. Because management is largely lifestyle-based, patients are encouraged to take an active role in their own care, making it important to understand which complementary approaches have genuine evidence behind them and which do not.

Is aloe vera actually good for fatty liver?

Aloe vera is not recommended for fatty liver disease by any UK clinical guideline, and current evidence does not support it as an effective treatment. Existing research is largely preclinical and should not be used as a basis for self-treating a liver condition.

The current evidence does not support aloe vera as an established or recommended treatment for fatty liver disease, and no UK clinical guideline from NICE, the NHS or the British Liver Trust endorses its use for this purpose. Aloe vera is a succulent plant whose gel and latex have been used in traditional medicine for centuries, primarily for skin conditions and digestive complaints. Interest in its potential liver effects has grown in recent years, largely driven by small laboratory and animal studies suggesting it may have anti-inflammatory and antioxidant properties.

However, interest in a substance is not the same as evidence of clinical benefit. The studies conducted so far are predominantly preclinical, meaning they have been carried out in cell cultures or animal models rather than in human clinical trials. Translating findings from these settings to human health outcomes is not straightforward, and results that appear promising in the laboratory frequently do not replicate in well-designed human trials.

For people seeking support with fatty liver management, Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online health consultations, with prescriber review and pharmacist support, where clinically appropriate options can be discussed. It is important to approach claims about aloe vera and liver health with caution, particularly when they appear on commercial websites promoting supplements. At present, aloe vera should be considered a subject of early-stage scientific curiosity rather than a proven liver therapy, and it should not replace the lifestyle interventions that do have a robust evidence base.

What does the current evidence say about aloe vera and liver health?

Evidence on aloe vera and liver health is predominantly from animal studies and small, low-quality human trials, with no large randomised controlled trial in MASLD. Published case reports have also described liver injury associated with oral aloe vera preparations.

Most of the available evidence on aloe vera and liver health comes from animal studies and small, short-duration human trials, and the overall quality of this evidence is low. Several rodent studies have found that aloe vera extracts, particularly those rich in compounds such as aloin, acemannan and anthraquinones, may reduce markers of liver inflammation and oxidative stress. Some animal models of diet-induced fatty liver have shown reductions in liver fat and liver enzyme levels following aloe vera supplementation.

A small number of human studies have explored aloe vera's effects on metabolic parameters. A few trials in people with prediabetes or metabolic syndrome reported modest reductions in fasting blood glucose and lipid levels, which are indirectly relevant to MASLD.^[18] However, these studies were generally limited by small sample sizes, short follow-up periods, lack of blinding and inconsistent dosing of aloe vera preparations. To our knowledge, as of the date of this article, no large, well-designed randomised controlled trial has specifically examined aloe vera's effect on liver fat, liver fibrosis or clinical outcomes in people with MASLD.

It is also worth noting that published case reports have described liver injury associated with oral aloe vera preparations, which adds an important safety dimension to the evidence picture.^[7][8] Aloe vera products also vary considerably in their composition, concentration and processing method, making it difficult to compare results across studies or to draw firm conclusions about any particular commercial product. The British Liver Trust does not currently recommend aloe vera as part of liver disease management. Until robust human trial data are available, clinicians and patients should treat existing findings as hypothesis-generating rather than conclusive, and should not use them as a basis for self-treating a diagnosed liver condition.

Are there any safety concerns or side effects with taking aloe vera?

Aloe latex can cause electrolyte disturbances, abdominal cramping and potential liver toxicity, and the European Medicines Agency does not recommend its prolonged internal use. Aloe vera may also interact with digoxin, diuretics, diabetes medicines and anticoagulants.

Aloe vera is not without risk, and several safety concerns are relevant to anyone considering it for liver health specifically. The two main forms used internally are aloe vera gel (derived from the inner leaf) and aloe latex (a yellow substance from just beneath the leaf skin). These have distinct compositions and different safety profiles, and they should not be treated as interchangeable.

Aloe latex contains anthraquinone compounds, including aloin, which have a potent laxative effect. Prolonged or high-dose use of aloe latex has been associated with electrolyte disturbances (particularly low potassium), abdominal cramping and, in animal studies at high doses, potential hepatotoxicity (liver toxicity).^[10][11] This is particularly relevant here: a substance being investigated for liver benefit could, in certain forms or doses, actually cause liver harm. The European Medicines Agency has raised concerns about the safety of hydroxyanthracene derivatives, including those found in aloe latex, and does not recommend their prolonged internal use.^[10][11] Aloe latex should be avoided during pregnancy and breastfeeding, and anyone who is pregnant, breastfeeding or planning a pregnancy should not take any oral aloe product without first discussing it with a clinician.

Aloe vera gel is generally considered safer when used in food-grade preparations, but it can still cause gastrointestinal upset in some people, and allergic reactions are possible. There are also potential interactions with certain medicines: the low potassium caused by aloe latex can increase the risk of side effects from digoxin and may interact with diuretics; aloe may also affect the action of diabetes medicines and anticoagulants.^[10][11] Anyone taking these medicines should seek advice before using any oral aloe product.

Anyone who experiences unexplained jaundice, dark urine, pale stools, persistent abdominal pain or significant fatigue should contact their GP promptly, as these may indicate liver problems requiring investigation. Suspected adverse reactions to any supplement can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

What lifestyle changes are recommended for fatty liver in the UK?

NICE guidance (NG49) recommends weight loss of 7 to 10 per cent, a Mediterranean-style diet, at least 150 minutes of moderate physical activity per week and alcohol reduction as the main interventions for MASLD. These lifestyle measures have a substantially stronger evidence base than any supplement.

Lifestyle modification remains the cornerstone of fatty liver management in the UK, and the evidence supporting it is substantially stronger than for any supplement, including aloe vera. NICE guidance (NG49) and NHS clinical pathways consistently recommend the following approaches for people with MASLD:

Weight management: Clinical studies and NICE NG49 indicate that losing 7 to 10 per cent of body weight can significantly reduce liver fat and, in some cases, reverse early fibrosis. Even modest weight loss of 3 to 5 per cent can reduce liver fat content. Gradual, sustained weight loss is preferred over rapid weight loss, which can paradoxically worsen liver inflammation.^[22] NHS tiered weight management services (Tier 2 to Tier 4) are available in many areas, though access may vary depending on local integrated care board (ICB) commissioning.

Dietary changes: A Mediterranean-style diet, rich in vegetables, legumes, wholegrains, oily fish and olive oil, and low in ultra-processed foods, added sugars and saturated fats, is widely recommended. Reducing intake of sugary drinks and foods high in fructose is specifically highlighted in liver health guidance from bodies including the British Liver Trust and international liver disease guidelines.

Physical activity: Both aerobic exercise and resistance training have been shown to reduce liver fat independently of weight loss.^[16][17] The UK Chief Medical Officers' physical activity guidelines recommend at least 150 minutes of moderate-intensity activity per week for adults, and this target is reflected in NHS guidance.^[12][13]

Alcohol reduction: Even in MASLD (which is not caused by alcohol), reducing alcohol intake is advisable, as alcohol places additional strain on the liver.

Managing metabolic risk factors: Controlling blood glucose, blood pressure and cholesterol through appropriate medical management is an important part of reducing liver disease progression.

These interventions are supported by robust clinical evidence and are available through NHS primary care, dietetic services and structured weight management programmes. They should form the foundation of any approach to fatty liver, regardless of whether complementary options are also being considered.

Should you talk to your GP before trying aloe vera for liver health?

Yes, speaking to your GP before taking aloe vera is strongly advisable if you have a liver condition, take regular medicines or have diabetes or kidney disease. Your GP can review liver function tests, check for drug interactions and refer you to a hepatologist or dietitian if needed.

Yes, speaking to your GP before taking aloe vera for fatty liver is strongly advisable, particularly if you have a confirmed liver condition, take regular medicines or have other health conditions such as diabetes or kidney disease. Although aloe vera gel is widely available as a food supplement without a prescription, this does not mean it is without risk. In the UK, food supplements are regulated under food law rather than medicines law, which means they face less stringent pre-marketing checks on quality, efficacy and safety than licensed medicines; product contents, concentration and purity can therefore vary considerably between brands.^[15] The Food Standards Agency (FSA) provides guidance on food supplements for UK consumers.

Your GP can review your current liver function tests and overall health picture, advise on whether any supplement is appropriate for you, and check for potential interactions with prescribed medicines. If you have been diagnosed with MASLD or another liver condition, your GP may also refer you to a hepatologist or dietitian, who can provide tailored, evidence-based support.

It is worth being transparent with your GP about any supplements you are already taking, as some can affect liver enzyme readings and complicate the interpretation of blood test results. This is especially important if you are due to have liver function tests as part of routine monitoring, or if you are planning surgery or starting new prescribed medicines.

If you develop any new or worsening symptoms, including yellowing of the skin or eyes, persistent nausea, unexplained fatigue or upper abdominal discomfort, contact your GP. For urgent concerns outside of GP hours, NHS 111 can provide advice. Do not delay seeking medical attention in favour of trying a supplement, and do not stop prescribed treatments without discussing this with your doctor first. Aloe vera may be a subject of ongoing research, but it is not a substitute for evidence-based medical care.

Scientific References

1. Non-alcoholic fatty liver disease (NAFLD).
2. Epidemiology of metabolic dysfunction-associated steatotic liver disease.
3. Metabolic dysfunction-associated steatotic liver disease (NG49).
4. NG49 Recommendations for research – metabolic dysfunction-associated steatotic liver disease.
5. Resmetirom (Rezdiffra) authorised to treat metabolic dysfunction-associated steatohepatitis (MASH) in adults.
6. Draft scope post-referral – GID-TA11477 (no medicines approved for MASLD/MASH in the UK).
7. Aloe vera-induced acute liver injury: A case report and review.
8. Aloe-induced toxic hepatitis.
9. Oral aloe vera-induced hepatitis.
10. Interim position on the safety of hydroxyanthracene derivatives for use in food.
11. Safety of hydroxyanthracene derivatives for use in food.
12. Physical activity guidelines: UK Chief Medical Officers' report.
13. UK Chief Medical Officers' physical activity guidelines (full report).
14. Physical activity guidelines for adults aged 19 to 64.
15. Food supplements – guidance for businesses.
16. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of body weight changes.
17. Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis.
18. Effects of Aloe vera supplementation in subjects with prediabetes/metabolic syndrome.
19. Impact of weight loss and reduction of ultra-processed foods on liver fat content in MASLD: A randomized controlled trial.
20. A culturally adapted online Mediterranean diet intervention for metabolic dysfunction-associated steatotic liver disease (TIMA): study protocol for a randomized controlled trial.
21. Very low energy ketogenic diet vs. Mediterranean diet for MASLD: Superior steatosis reduction in a randomised pilot study.
22. Rapid Reversal of Liver Steatosis With Life Style Modification in Highly Motivated Liver Donors.

Frequently Asked Questions